ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W955. A total of 5 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $734,517 | +507.0% | 1,179 | +555.0% | 0.64% | +320.9% |
| Q3 2022 | $121,000 | -99.7% | 180 | -97.9% | 0.15% | -98.2% |
| Q4 2018 | $38,948,000 | +31.2% | 8,467 | +26.5% | 8.57% | +125.5% |
| Q3 2018 | $29,692,000 | +8.4% | 6,692 | -4.2% | 3.80% | -10.2% |
| Q2 2018 | $27,386,000 | -68.7% | 6,988 | -42.3% | 4.23% | -19.1% |
| Q1 2018 | $87,562,000 | +696.4% | 12,106 | +624.9% | 5.23% | +422.2% |
| Q4 2017 | $10,995,000 | +48.3% | 1,670 | +12.9% | 1.00% | +106.8% |
| Q3 2017 | $7,413,000 | +523.5% | 1,479 | +475.5% | 0.48% | +520.5% |
| Q2 2017 | $1,189,000 | +31.1% | 257 | 0.0% | 0.08% | +59.2% |
| Q1 2017 | $907,000 | -72.2% | 257 | -35.6% | 0.05% | -58.8% |
| Q2 2015 | $3,262,000 | – | 399 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 12,106 | $87,562,000 | 5.23% |
| Iguana Healthcare Management, LLC | 50,000 | $3,617,000 | 2.38% |
| BOOTHBAY FUND MANAGEMENT, LLC | 189 | $1,367,000 | 0.16% |
| GROUP ONE TRADING, L.P. | 37,900 | $2,741,000 | 0.03% |
| SIMPLEX TRADING, LLC | 259 | $110,000 | 0.01% |